Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..
BACKGROUND: Opisthorchis viverrini (Ov) infection-induced cholangiocarcinoma (CCA) is a major public health problem in northeastern Thailand. Praziquantel was shown to prevent CCA development in an Ov-infected hamster model; however, the molecular mechanism remains unknown.
MATERIALS AND METHODS: In this study, we used a hamster model with Ov and N-nitrosodimethylamine-induced CCA to study the mechanisms of praziquantel action. The liver tissues from the hamsters with and without praziquantel treatment were analyzed using 1H nuclear magnetic resonance spectroscopy.
RESULTS: A total of 14 metabolites were found to be significantly different between the two groups. Furthermore, the combination of acetate, inosine and sarcosine was shown to exert an anti-inflammatory effect through interleukin-6 inhibition in a macrophage cell line, suggesting a mechanism by which praziquantel may prevent inflammation caused by Ov, cholangiocyte transformation and further CCA develpoment.
CONCLUSION: These findings might avail the development of a preventive strategy for CCA in high-risk populations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Cancer genomics & proteomics - 18(2021), 1 vom: 08. Jan., Seite 29-42 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Prommajun, Pattama [VerfasserIn] |
---|
Links: |
---|
Themen: |
6490C9U457 |
---|
Anmerkungen: |
Date Completed 20.08.2021 Date Revised 10.02.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.21873/cgp.20239 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319834956 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319834956 | ||
003 | DE-627 | ||
005 | 20231225172310.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21873/cgp.20239 |2 doi | |
028 | 5 | 2 | |a pubmed24n1066.xml |
035 | |a (DE-627)NLM319834956 | ||
035 | |a (NLM)33419894 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Prommajun, Pattama |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.08.2021 | ||
500 | |a Date Revised 10.02.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | ||
520 | |a BACKGROUND: Opisthorchis viverrini (Ov) infection-induced cholangiocarcinoma (CCA) is a major public health problem in northeastern Thailand. Praziquantel was shown to prevent CCA development in an Ov-infected hamster model; however, the molecular mechanism remains unknown | ||
520 | |a MATERIALS AND METHODS: In this study, we used a hamster model with Ov and N-nitrosodimethylamine-induced CCA to study the mechanisms of praziquantel action. The liver tissues from the hamsters with and without praziquantel treatment were analyzed using 1H nuclear magnetic resonance spectroscopy | ||
520 | |a RESULTS: A total of 14 metabolites were found to be significantly different between the two groups. Furthermore, the combination of acetate, inosine and sarcosine was shown to exert an anti-inflammatory effect through interleukin-6 inhibition in a macrophage cell line, suggesting a mechanism by which praziquantel may prevent inflammation caused by Ov, cholangiocyte transformation and further CCA develpoment | ||
520 | |a CONCLUSION: These findings might avail the development of a preventive strategy for CCA in high-risk populations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Praziquantel | |
650 | 4 | |a anti-inflammation | |
650 | 4 | |a cholangiocarcinoma | |
650 | 4 | |a metabolic profiling | |
650 | 4 | |a nuclear magnetic resonance spectroscopy. | |
650 | 7 | |a Anthelmintics |2 NLM | |
650 | 7 | |a Praziquantel |2 NLM | |
650 | 7 | |a 6490C9U457 |2 NLM | |
700 | 1 | |a Phetcharaburanin, Jutarop |e verfasserin |4 aut | |
700 | 1 | |a Namwat, Nisana |e verfasserin |4 aut | |
700 | 1 | |a Klanrit, Poramate |e verfasserin |4 aut | |
700 | 1 | |a Sa-Ngiamwibool, Prakasit |e verfasserin |4 aut | |
700 | 1 | |a Thanee, Malinee |e verfasserin |4 aut | |
700 | 1 | |a Dokduang, Hasaya |e verfasserin |4 aut | |
700 | 1 | |a Kittirat, Yingpinyapat |e verfasserin |4 aut | |
700 | 1 | |a Li, Jia V |e verfasserin |4 aut | |
700 | 1 | |a Loilome, Watcharin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer genomics & proteomics |d 2004 |g 18(2021), 1 vom: 08. Jan., Seite 29-42 |w (DE-627)NLM172378877 |x 1790-6245 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:08 |g month:01 |g pages:29-42 |
856 | 4 | 0 | |u http://dx.doi.org/10.21873/cgp.20239 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2021 |e 1 |b 08 |c 01 |h 29-42 |